Résultats de la recherche - 5 results
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
the following six months. The trial is registered on ClinicalTrials.gov (NCT04527614). FINDINGS: All included residents (n = 85) and staff members (n = 88) were SARS-CoV-2 infection naïve at third dose ...
SARS-CoV-2 Surveillance in Belgian Wastewaters
for 15 months comprising three major virus waves. During the entire period, a high correlation was observed between the daily new COVID-19 cases and the SARS-CoV-2 concentration in wastewater corrected ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
3 months (but more than 2 weeks ago), the prevalence of anti- SARS-CoV-2 antibodies was 97.9% in the first period of wave 2 (27/09-24/10) and 99.1% in the second period (25/10-21/11). Among the fully ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
seasonal hCoV with the highest prevalence across age groups and highest incidence in children admitted to hospital who were younger than 5 years (incidence 9·0 [95% CI 7·2-11·2] per 100 000 person-months ...
All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century.
historical mortality, monthly mortality rates were calculated from January 1900 to June 2020. RESULTS: Nine thousand five hundred ninety-one COVID-19 deaths and 39,076 deaths from all-causes were recorded, ...